Amanta Healthcare IPO Subscription Opens Sep 1: GMP Already Signals 17% Listing Profit

Amanta Healthcare Limited is launching its IPO from September 1 to September 3, 2025, aiming to raise Rs. 126 crore through a fresh issue of 1 crore equity shares. The price band is set at Rs. 120 to Rs. 126 per share, and the minimum lot size is 119 shares, suitable for retail investors seeking exposure to a growing pharmaceutical manufacturer.

The Amanta Healthcare IPO GMP has already touched Rs. 22, indicating an estimated 17.46% gain over the upper price band of Rs. 126 per share. Investors have already put high expectations ahead of the IPO subscription opening.

Amanta Healthcare IPO Details

The Amanta Healthcare IPO, worth Rs. 126 crore and comprising 1 crore shares, is set to open for subscription on September 1st and will close on September 3rd. The allotment process is expected to conclude by September 4th, with a tentative listing on BSE and NSE scheduled for September 9th.

The proceeds from the Amanta Healthcare IPO will be primarily used to fund the company's expansion of manufacturing lines in Hariyala, Kheda, Gujarat.

As per RHP, about 70% of the funds will be used for civil construction and purchase of equipment, plant, and machinery for the SteriPort manufacturing line. While around 30.13% of proceeds will be allocated to civil construction and equipment for the SVP manufacturing line.

The remaining funds will support general corporate purposes.

With a post-IPO market capitalisation of Rs. 489 crore and a PE ratio of 46.59x, Amanta Healthcare is reasonably priced among its pharmaceutical peers, while at a slight premium.

About Amanta Healthcare

Founded in 1994 in Ahmedabad, Amanta Healthcare specialises in sterile liquid pharmaceuticals, including IV fluids, injectables, ophthalmic products, and respiratory care solutions. The company is leveraging advanced packaging technologies like Aseptic Blow-Fill-Seal and ISBM; the company serves both the domestic market and exports to 21 countries. In FY25 Amanta Healthcare posted revenue of Rs. 274.7 crore and a profit after tax (PAT) of Rs. 10.5 crore, a significant increase from Rs. 3.63 crore in FY24. EBITDA margin stood at 22.22%, with PAT margin improving to 3.82%.